Third JAK Inhibitor for Alopecia Areata Wins FDA Approval
MedPage Today) — The FDA approved the oral Janus kinase (JAK) inhibitor deuruxolitinib (Leqselvi) to treat alopecia areata, drugmaker Sun Pharmaceutical announced on Thursday. The approval stipulates use of deuruxolitinib in adults with severe…
MedPage Today) — The FDA approved the oral Janus kinase (JAK) inhibitor deuruxolitinib (Leqselvi) to treat alopecia areata, drugmaker Sun Pharmaceutical announced on Thursday.
The approval stipulates use of deuruxolitinib in adults with severe…
Read More
About Author
